Search the Newsreel

Murphy Oil (MUR) Stock Still Looks Cheap Despite A 109% Return

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Murphy Oil stock has delivered a strong 108.8% return over the past five years, …

BridgeBio Pharma (BBIO) Secured Two Priority Reviews For Rare Disease Drugs

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. BridgeBio Pharma (NasdaqGS:BBIO) reports recent clinical and regulatory milestones across late-stage rare disease assets, including acoramidis, BBP-418, and encaleret. Acoramidis continues to show differentiated …

GSA Capital Partners LLP Makes New Investment in Murphy USA Inc. $MUSA

GSA Capital Partners LLP has acquired a new stake in Murphy USA Inc. (NYSE:MUSA) by purchasing 8,038 shares valued at approximately $4.33 million in the second quarter, making it their 20th-largest holding. Institutional investors now own 80.81% of Murphy USA, which recently reported strong …

Is Ionis Pharmaceuticals (IONS) Undervalued Following Its Pullback?

Daiwa Securities Group Inc. Decreases Stock Position in Phillips 66 $PSX

Philip Morris International Inc. $PM Shares Bought by Crew Capital Management Ltd

Crew Capital Management Ltd significantly increased its stake in Philip Morris International (NYSE:PM) by 287.2% in the second quarter, now holding 7,503 shares valued at approximately $1.36 million. Analysts maintain a "Moderate Buy" rating for PM, with a consensus target price of $205.89. The …

Alphabet Inc. $GOOG is Everett Harris & Co. CA's 4th Largest Position

Everett Harris & Co. CA has made Alphabet Inc. ($GOOG) its fourth-largest position, despite a slight trim in their holdings. The company's strong financial performance, positive analyst ratings, and significant investment from Berkshire Hathaway highlight investor confidence, though competitive pressures in AI and insider …

Heritage Investors Management Corp Sells 9,615 Shares of ConocoPhillips $COP

Heritage Investors Management Corp reduced its stake in ConocoPhillips (NYSE:COP) by 4.8% in the second quarter, selling 9,615 shares, though still holding 189,417 shares worth approximately $19.7 million. ConocoPhillips reported strong Q2 results with EPS of $3.24 and revenue up 32.4% year over year, …

Ionis (IONS) Stock Looks Like A Bargain On Value But Full On Sales

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Ionis Pharmaceuticals stock carries a strong three year return record alongside a high overall value score, yet current market multiples still point to the shares …

Caitong International Asset Management Co. Ltd Raises Stock Position in ConocoPhillips $COP

Caitong International Asset Management Co. Ltd significantly increased its stake in ConocoPhillips (NYSE:COP) by 3,112.4% in the second quarter, now owning 17,604 shares valued at $1.83 million. ConocoPhillips reported strong Q2 earnings with EPS beating estimates and revenue up 32.4% year-over-year, driven by record …

Blueprint Investment Partners LLC Invests $2.15 Million in Philip Morris International Inc. $PM

Blueprint Investment Partners LLC has acquired a new stake worth $2.15 million in Philip Morris International Inc. (NYSE:PM) during the second quarter. Other institutional investors have also increased their holdings in the company. Philip Morris International reported strong Q2 earnings, beating analyst estimates, and …

Empowered Funds LLC Buys 16,525 Shares of Alpha Metallurgical Resources, Inc. $AMR

Empowered Funds LLC increased its stake in Alpha Metallurgical Resources, Inc. (NYSE:AMR) by 79.4% in the first quarter, adding 16,525 shares and bringing its total holdings to 37,347 shares valued at approximately $7.7 million. Other institutional investors also adjusted their positions in AMR, which …

(ATEC) as a Liquidity Pulse for Institutional Tactics

This article provides an in-depth analysis of Alphatec Holdings Inc. (NASDAQ: ATEC), highlighting strong near and mid-term sentiment despite a weak long-term outlook. It details various institutional trading strategies, including position trading, momentum breakout, and risk hedging, based on AI-generated signals. The analysis also …

Philip Morris International Inc. $PM Shares Acquired by Acumen Wealth Advisors LLC

Acumen Wealth Advisors LLC significantly increased its stake in Philip Morris International Inc. (NYSE:PM) by 736.7% in the second quarter, now owning 9,815 shares valued at $1.79 million. Other major institutional investors like Vanguard Group Inc., Capital World Investors, and Bank of America Corp …

Alphabet Inc. $GOOGL Stock Position Cut by Agate Pass Investment Management LLC

Agate Pass Investment Management LLC reduced its stake in Alphabet Inc. (NASDAQ:GOOGL) by 10.9% in the second quarter, although Alphabet remains its largest holding. Despite this cut, other institutional investors like Norges Bank, Cardano Risk Management B.V., and Vanguard Group Inc. significantly increased their …

Phathom Pharmaceuticals (PHAT) Stock Sees Modest Fair Value Cut After Analyst Target Cuts

Phathom Pharmaceuticals (PHAT) has experienced a modest fair value cut from US$23.70 to US$21.50 following analyst target revisions. This adjustment is due to updated Q2 results, revised 2026 revenue guidance, and new perspectives on their drug Voquezna's commercial path. While some firms remain bullish …

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Rating of "Moderate Buy" by Brokerages

Tarsus Pharmaceuticals (NASDAQ:TARS) has received a "Moderate Buy" consensus rating from brokerages, with an average 12-month price target of $90.50, significantly higher than its current share price of $69.20. The company recently reported quarterly revenue of $173.91 million, surpassing estimates, but its loss per …

Citius Pharmaceuticals Reports LYMPHIR Revenue Growth, Explores CAR-T Combination

Citius Pharmaceuticals reported promising early results for its approved drug LYMPHIR in new indications, including an 86% objective response rate in a Phase 1 CAR-T combination trial for diffuse large B-cell lymphoma and a 24% ORR in gynecologic malignancies. The company also announced strong …

Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative?

Mirum Pharmaceuticals reported a significant net loss for Q2 and H1 2026, with basic loss per share rising, which highlights increased costs relative to revenue. This widening loss intensifies focus on cash burn and funding risks, despite upcoming clinical and regulatory catalysts such as …

Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Sell

Wall Street Zen has downgraded Mirum Pharmaceuticals (NASDAQ:MIRM) from "hold" to "sell," despite the company reporting better-than-expected quarterly revenue of $176.24 million, a 37.9% increase year-over-year. The downgrade comes as the company missed earnings per share estimates, reporting a loss of $1.06 against a …

Responsive Playbooks and the ETON Inflection

This article provides an AI-driven analysis for Eton Pharmaceuticals Inc. (NASDAQ: ETON), highlighting weak near and mid-term sentiment but a positive long-term outlook. It details specific trading strategies including position trading, momentum breakout, and risk hedging, along with multi-timeframe signal analysis. The report suggests …

Smith & Nephew SNATS (NYSE:SNN) Stock Rating Lowered by Wall Street Zen

Wall Street Zen downgraded Smith & Nephew SNATS (NYSE:SNN) from a "buy" to a "hold" rating, contributing to a mixed analyst sentiment with an overall "Hold" consensus and a $30.93 price target. The stock opened at $29.84, trading below its 50-day and 200-day moving …

Rigel Pharmaceuticals (RIGL) Stock Sees Fair Value Lift As Veppanu Launch Adds Growth Hope

Rigel Pharmaceuticals (RIGL) has seen its fair value estimate increase from US$51.6 to US$61.2 per share, primarily due to the launch of Veppanu in the U.S. and the international potential of Rezlidhia through a partnership with Kissei. Analysts, such as H.C. Wainwright, view Veppanu …

Why Eton Pharmaceuticals (ETON) Is Up 32.0% After Q2 Earnings Surge And Raised 2026 Outlook

Eton Pharmaceuticals (ETON) saw its stock rise 32.0% after reporting a significant Q2 2026 earnings turnaround, with revenue surging to US$37.59 million and net income reaching US$11.58 million. The company also raised its full-year 2026 revenue guidance to at least US$145 million and expanded …

Enterprise value to revenue forward of Rhythm Pharmaceuticals, Inc. – DUS:1RV

This article provides financial data for Rhythm Pharmaceuticals, Inc. (DUS:1RV) on the Dusseldorf Stock Exchange, specifically focusing on its enterprise value to revenue forward. It notes that the market is closed with no trades recorded at the time of publication. The content is presented …

Marksans Pharma Limited (NSE:MARKSANS) Looks Like A Good Stock, And It's Going Ex-Dividend Soon

PHR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Phreesia, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) for alleged violations of federal securities laws. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing …

Phillips 66 SVP and controller Kluppel sells $1.65m in stock

Ann M. Kluppel, Phillips 66's SVP and Controller, sold company stock worth $1.65 million in early August, following the exercise of employee stock options. The sales occurred when the stock was trading near its 52-week high, having delivered significant year-to-date and past-year returns. Despite …

Top Pyrophyte Acquisition Corp. II (PAII) Competitors 2026

Jim Cramer Continued To Keep The Faith In Ralph Lauren Corporation (NYSE:RL) CEO

Luxury apparel giant Ralph Lauren Corporation (NYSE:RL)'s shares are up by 33.8% over the past year and by 7.3% year-to-date. As evidenced by its share price, the firm has performed well over the past year. On the 6th, the day Cramer discussed Ralph Lauren …

Berkshire Hathaway boosted stake in Alphabet, homebuilders in the second quarter

Berkshire Hathaway is increasing the size of its stake in Google's parent company and beefing up its holdings in homebuilders, according to the conglomerate's latest snapshot of its investment portfolio. The Omaha, Nebraska-based company also continued to pare its stake in financial companies and …

US Physical Therapy Appoints New Executive Vice President CFO

Shanghai Fudan Zhangjiang Bio Pharmaceutical Ltd (SEHK:1349) Stock Profit Rebound Raises Durability Questions

PARADEEP Share Price Today - Paradeep Phosphates on NSE/BSE

Why Eton Pharmaceuticals Shares Are Trading Higher By 22%; Here Are 20 Stocks Moving Premarket

Eton Pharmaceuticals (NASDAQ: ETON) saw its shares rise significantly in pre-market trading after reporting stronger-than-expected second-quarter financial results and providing an optimistic revenue guidance for FY26. The company exceeded analyst consensus estimates for both earnings per share and sales. The article also lists other …

Is Teva Pharmaceutical Industries (TEVA) A Bargain On Its TEV 408 Phase 2b Move?

Teva Pharmaceutical Industries (TEVA) has initiated a phase 2b trial for its anti IL-15 antibody TEV-'408 for nonsegmental vitiligo, following promising phase 1b results. This development, coupled with a significant 1-year share price return of 105.88%, has renewed investor interest. While the stock is …